Chinese VC Lilly Asia leads $20m Series A round in genetic testing firm Singlera

Chinese VC Lilly Asia leads $20m Series A round in genetic testing firm Singlera

Shanghai-based venture capital firm Lilly Asia Ventures has led a $20-million Series A financing round in a fast-growing, non-invasive genetic testing company Singlera Genomics.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter